NCT07158723

Brief Summary

Polycystic ovary syndrome (PCOS) is a significant public health problem and is one of the most common hormonal disturbances affecting women of reproductive age. Women with PCOS are often insulin resistant, increasing their risk for cardiometabolic health problems (e.g., type 2 diabetes, heart disease, high blood pressure, sleep apnea, anxiety, depression, and stroke) especially if they are overweight. Lifestyle modifications, including dietary changes and regular physical activity, may alleviate metabolic dysfunction in women with PCOS and are often the first line of management for patients with PCOS. Several studies have identified protein as a key nutrient for regulation of energy balance, maintenance of skeletal muscle mass, and improving cardiometabolic health across the lifespan. However, the effect of increased protein intake (30% of total energy intake) on cardiometabolic health in women with PCOS has not been well-defined and mechanisms for these effects have not been identified. There is an evident need for well-designed, randomized controlled trials evaluating the efficacy of increased protein intake in women with PCOS on markers of cardiometabolic health. Preliminary data from collaborative projects with the investigators on this proposal suggest that increasing protein in the diet has the potential to improve markers of cardiometabolic health, potentially through improvements in body composition and/or changes in cortisol, energy metabolism, inflammation, and neurological regulators

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
19mo left

Started Aug 2025

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress33%
Aug 2025Dec 2027

Study Start

First participant enrolled

August 1, 2025

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

August 19, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

September 8, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 3, 2027

Last Updated

September 8, 2025

Status Verified

September 1, 2025

Enrollment Period

1.9 years

First QC Date

August 19, 2025

Last Update Submit

September 2, 2025

Conditions

Keywords

PCOSpolycystic ovary syndromeproteinwomenwellbeingmetabolism

Outcome Measures

Primary Outcomes (1)

  • Lean body mass

    Lean body mass will be measured using dual x-ray absorptiometry.

    0 and 16 weeks.

Secondary Outcomes (8)

  • Body fat mass

    0 and 16 weeks

  • Sleep Duration

    Sleep will be measured every 8 weeks (0, 8, and 16 weeks)

  • Mood

    Every 4 weeks (0, 4, 8, 12, 16 weeks)

  • Quality of Life perception

    Every 4 weeks (0, 4, 8, 12, and 16 weeks)

  • Energy expenditure

    Every 4 weeks (0, 4, 8, 12 and 16 weeks)

  • +3 more secondary outcomes

Study Arms (4)

Calorie restricted control

ACTIVE COMPARATOR
Other: Calorie restriction

Control and Protein

ACTIVE COMPARATOR
Other: Higher protein dietary pattern

Calorie restricted PCOS

ACTIVE COMPARATOR
Other: Calorie restriction

PCOS Protein

ACTIVE COMPARATOR
Other: Higher protein dietary pattern

Interventions

Follow energy-restricted (10% calorie reduction), higher protein dietary pattern (1.6 g protein/kg body weight)

Control and ProteinPCOS Protein

Follow energy-restricted (10% calorie reduction) dietary pattern for 16 weeks. No restrictions on macronutrient content.

Calorie restricted PCOSCalorie restricted control

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Females ages 18-50 years
  • Confirmed diagnosis of PCOS
  • Body mass index (BMI) between 18.5 and 35 kg/m2
  • Stable body weight for at least 3 months (+ 5 pounds)
  • Willingness to consume both plant- and animal-based protein meals

You may not qualify if:

  • Smoking or use of nicotine products
  • Smoking, vaping, and/or use of marijuana products
  • More than 4 alcoholic beverages per week
  • Food allergies or dietary restrictions incompatible with test meals
  • Diagnosed diabetes (type 1 or 2) or other preexisting chronic disease(s).
  • Use of medications that interfere with study outcomes (e.g., metformin, GLP-1 agonists, etc.)
  • Consumption of more than 0.8 g/protein/kg body weight
  • Underweight
  • Taking nutritional supplements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Center for Human Nutrition

Fayetteville, Arkansas, 72704, United States

RECRUITING

Center for Human Nutrition

Fayetteville, Arkansas, 72704, United States

RECRUITING

MeSH Terms

Conditions

Polycystic Ovary Syndrome

Interventions

Caloric Restriction

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsEnergy IntakeDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 19, 2025

First Posted

September 8, 2025

Study Start

August 1, 2025

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

December 3, 2027

Last Updated

September 8, 2025

Record last verified: 2025-09

Locations